Drag a card by its title · ⚙ to size, swap or remove

The company

Decoy Therapeutics Inc.

DCOY · Nasdaq

Health CareBiotechnologyNot moving yet

DCOY stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 78.4% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 52
Industry in uptrend: 18% -9 in 4 wk
Insider buys, 12 months: $20K
Insider sales, 12 months: $35
Officials’ trades on record: 0
Institutions holding: 4 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

23 Apr – 22 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2

Sale orders, 12 months1

Buyers · sellers2 · 1

Who	Did	Shares	Traded
Arnold C. HanishDirector	sold	15at $0.6397	30 Dec 2025filed 2 Jan 2026
Arnold C. HanishDirector	sold	12at $0.6397	30 Dec 2025filed 2 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders4+0 on the quarter

New · exited2 · 2

Reported value$31K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026	4,034$29K	+4,034
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026	256$1,841	-765−74.9%
UBS Group AGreduced · filed 13 Aug 2026	25$180	-521−95.4%
Caitong International Asset Management Co., Ltdnew · filed 5 Aug 2026	2$14	+2